During the past decade, Memorial Healthcare System conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 16 clinical trials were completed, i.e. on average, 30.2% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 11 clinical trials were completed. i.e. 40.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Healthcare System" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Memorial Healthcare System" with 6 trials sponsored, "Alliance Foundation Trials, LLC." with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Clovis Oncology, Inc." with 2 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Healthcare System" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Foundation Medicine" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Healthcare System" are "Breast Cancer" (5 trials), "Non-small Cell Lung Cancer" (4 trials), "Breast Neoplasms" (3 trials), "Melanoma" (3 trials) and "Sickle Cell Disease" (3 trials). Many other conditions were trialed in "Memorial Healthcare System" in a lesser frequency.

Most popular intervention types in "Memorial Healthcare System" are "Drug" (38 trials), "Device" (11 trials), "Other" (9 trials), "Biological" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Fulvestrant" (4 trials), "Atezolizumab" (2 trials), "Capecitabine" (2 trials) and "Crovalimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Healthcare System" are 57 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Healthcare System". undefined are not yet recruiting, 18 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Memorial Healthcare System, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Healthcare System, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".